Summary A bladder carcinoma cell line (J82) was selected for resistance to the new vinca alkaloid navelbine. The resistance factor of the resistant subline (J82-NVB) to navelbine was 17. P-glycoprotein was not detected in the membrane of J82-NVB cells. The lack of cross-resistance to multidrug-resistant (MDR) drugs such as doxorubicin, epipodophyllotoxins and colchicine, the absence of increase in navelbine efflux and the fact that a reduced accumulation of the drug cannot account for the resistance level confirmed that the phenotype of resistance of J82-NVB cells is not a classical MDR phenotype. Moreover, verapamil did not reverse the resistance of J82-NVB cells. The cells were cross-resistant to vinca alkaloids and taxoids which share the same target protein: tubulin. Analysis of microtubules using immunofluorescence showed that disassembly of the microtubular network occurred for the same concentration of navelbine in sensitive and resistant cells. However, after treatment with a concentration of navelbine inducing depolymerisation in both sensitive and resistant cells, reassembly of the microtubular network was observed only in resistant cells. This study suggests that the mechanism of resistance of J82-NVB cells involves recovery from the inhibition of microtubule dynamics induced by drug treatment.
The human bladder carcinoma cell line J82 (O'Toole et al., 1978) was supplied by Pierre Fabre laboratories. The resistant subline J82-NVB was obtained by continuous exposure to increasing NVB concentrations from 1 to 10 nM and then maintained at 10 nM (Pauwels & Kiss, 1991) . The resistance of J82-NVB cells was stable, since it was not decreased after 3 months of culture in the absence of drug. K562 is a human leukaemia cell line established from a patient with chronic myelogenous leukaemia in blast transformation (Lozzio & Lozzio, 1975) . Three resistant sublines (K562-NVB 50, 100, 200) were obtained by continuous exposure to increasing NVB concentrations from 50 to 200 nM over a period of 12 months. The sublines obtained at each step were then maintained at 50, 100 and 200 nM NVB respectively. All cell lines were grown in RPMI-1640 culture medium (Gibco, Cergy Pontoise, France) supplemented with 10% fetal calf serum (Institut Jacques Boy, Reims, France) in a moist air/carbon dioxide incubator at 37C. J82 and J82-NVB cells were maintained as monolayers and K562 and K562-NVB cells were suspended in the culture medium in 80 cm2 Nunc culture flasks (Poly Labo, Strasbourg, France) . For the trypsination of J82 cells, a trypsin/EDTA solution 0.05/0.02% (w/v) in Ca2'-and Mg2+-free PBS was used.
For drug uptake and efflux, cells in exponential growth phase were plated and maintained in drug-free medium for 2 days and then incubated at a density of 4 x I05 cells ml-' in RPMI medium containing the appropriate drug concentration and for the appropriate time in 80cm2 (200-250 cells mm-2) or 175 cm2 (2,000-2,200 cells mm-2) culture flasks.
Cell densities and viability were determined by phase-contrast microscopy with 0.1% trypan blue.
General cell characteristics Population doubling times were determined from daily cell counts of triplicate cell samples incubated for 5 days in Nunc 24-well plates (Poly Labo). Cell counts were performed by microscopy, and doubling times were determined during the exponential growth phase. Cell diameters were measured on trypsinised cells by microscopy, using a micrometer. Cell protein contents were determined by the method of Lowry et al. (1951) . DNA contents were determined by fluorescence measurement after reaction with DABA (Fiszer-Szafarz et al., 1981) .
Cell cycle analysis DNA content was assessed using propidium iodide staining of naked nuclei according to Vindelov et al. (1983) , and analysed with a flow cytometer (Cytofluorograf 50H, Ortho Instruments, Westwood MA, USA) connected to a MCA-3000 computer (Bruker, Wissembourg, France) .
Growth inhibition assay K562, K562-NVB, J82 and J82-NVB cell lines in exponential growth phase were incubated in triplicate at 4 x I05cells ml' for 1 h at the appropriate drug concentration in 24-well plates (Poly Labo) under the same conditions as described for drug uptake. The treated cells were then washed twice with PBS at 4°C. K562 and K562-NVB cells were resuspended for 72 h in drug-free culture medium. J82 and J82-NVB treated cells were kept in dishes in drug-free medium for 72 h. For exposures in the presence of verapamil, cells were coincubated for 1 h with 5 l4M verapamil and navelbine, washed in PBS and incubated for 72 h in medium containing 5 LM verapamil but without navelbine. Cell numbers were then determined using phase-contrast microscopy. The percentage of growth inhibition compared with untreated controls was plotted against the drug concentration. IC50, defined as the concentration of drug that reduced cell growth by 50%, was interpolated from the curves. Resistance factors were determined by dividing the IC50 of resistant cells by that of sensitive cells.
Determination of the intracellular concentration of navelbine by high-performance liquid chromatography Accumulation and efflux of navelbine in the tumour cells were determined as described previously (Debal et al., 1992) .
Briefly, samples of 2 x 106 cells were incubated in 5 ml of RPMI-1640 medium containing navelbine at the appropriate concentration. The cell suspensions (J82 and J82-NVB cells were scraped after incubation) were centrifuged for 10 min at 200 g. The pellets were washed twice with PBS. A 20 yIl aliquot of a 10-5 M vinblastine solution (internal standard) was added to each sample. Extraction was performed by addition of 200 tlI ethanol (pH 5.5) to each sample. Tubes were shaken, centrifuged and 25 ll of each supernatant was directly injected into the chromatograph.
The chromatographic system consisted of a Shimadzu LC7A solvent-delivery module (Touzart et Intranuclear measurements of anthracyclines by laser microspectrofluorimetry Fluorescence emission spectra from a microvolume of a living cell treated with THP-doxorubicin were recorded with a confocal microspectrofluorometer (modified Raman spectrometer OMARS 89, Dilor, Lille, France) as already described (Gigli et al., 1988 (Gigli et al., , 1989 .
Flow cytometric analysis of P-glycoprotein expression Direct immunofluorescence staining of P-glycoprotein was performed using the monoclonal anti P-glycoprotein C219 antibody coupled to fluorescein (FITC) . Immunostaining was performed as described elsewhere (Cuvier et al., 1992) .
Flow cytometric analyses were performed on a FACScan flow cytometer (Becton-Dickinson, Mountain View, CA, USA). The excitation source was an argon ion laser emitting at 488 nm. The green fluorescence, related to P-glycoprotein expression, was measured on a logarithmic scale.
Immunocytochemical staining of P-glycoprotein The cells were washed in PBS (J82 and J82-NVB cells were harvested with trypsin), applied to microscopic slides and air dried. They were then fixed with acetone at 4°C for 3 min, washed in tris-buffered saline (TBS, pH 7.6), and incubated successively with anti P-glycoprotein C219 antibody (10 tg ml-' in PBS/BSA) (P-glycocheck C219, Centocor) and unlabelled anti-mouse Ig (diluted at 1:25 in PBS/BSA). Slides were detected with alkaline phosphatase-mouse anti-alkaline phosphatase monoclonal antibody complexes (APAAP complexes) (diluted at 1:50 in PBS/BSA) using a substrate (naphthol As-MX phosphate, levamisole, fast red TR salt) red stained by alkaline phosphatase activity (Cordell et al., 1984) . After counterstaining with haematoxylin, slides were mounted in glycerol and examined by phase-contrast microscopy. The K562 myelogenous leukaemia cell line and the doxorubicin-resistant K562-ADM subline (Tsuruo et al., 1986b) were used as negative and positive control respectively.
RNA preparation and hybridisation Total cellular RNA from exponentially grown J82 or J82-NVB cells were prepared by the isothiocyanate/caesium chloride density gradient fractionation method (Sambrook et al., 1989) . The final RNA preparations were precipitated in ethanol and adjusted to a concentration of 1 mg ml-' in diethyl pyrocarbamate (DEPC)-treated water, then aliquoted and stored at -80°C. For the Northern blot analysis, 10 tg of each RNA sample was electrophoresed on 1% agarose gels containing formaldehyde, transferred to Hybond N+ membranes, and stained by ethidium bromide. The probes used were the human a-tubulin cDNA clone bal, in pUC ) and the human P-tubulin cDNA clone DPl, in pUC (Hall et al., 1983) , provided by Dr N.J. Cowan (NYU Medical Center, New York, NY, USA). The probes were nick-translated by E.
coli DNA polymerase with [a32P]dCTP (> 3,000 Ci mmol-1) as previously described (Sambrook et al., 1989) . Prehybridisation and hybridisation were done at 42°C in 10 ml of 50% formamide, 10 x Denhardt's solution, 100 jig ml-' salmon sperm DNA, 1% SDS, 5 x standard saline citrate (SSC) and 25 mM sodium phosphate pH 6.8. The heat-denatured probe was added after 3 h of prehybridisation, and the hybridisation reaction was left to run for 16 h. Membranes were successively hybridised with the a-tubulin and the P-tubulin probes. Membranes were washed as follows: once at room temperature in 2 x SSC, twice at 65°C in 0.5 x SSC, 0.1% SDS and twice at room temperature in 0.2 x SSC, 0.1% SDS. The blots were autoradiographed for 1 day on Hyperfilms MP (Amersham). Relative polymerised tubulin content determination Tubulin determination was performed using an enzymelinked immunoassay. Cells were plated at 9,000 per well (in 0.2 ml of medium) in 96 well plates, cultured for 2 days and then lysed and fixed as described (De Ines et al., 1994) . Cells were successively incubated with a mouse anti-a-tubulin antibody, an anti-mouse biotinylated IgG antibody, avidin and biotinylated horseradish peroxidase. Plates were then developed with peroxidase substrate kit (ABTS Vector). The absence of background was verified by omitting the first antibody.
Immunofluorescence study of microtubules J82 and J82-NVB cells were plated on Nunc quadruple well chamber slides in 1 ml of RPMI-1640 medium at 37°C for 2 days. Cells at 4 x I05 cells ml-' were then treated with navelbine (0, 50, 200, 1000, 2,000 nM) for 1 h at 37°C. Slides were washed with ice-cold PBS and cells were fixed in 3.7% formaldehyde in PBS at room temperature. Cells were then permeabilised successively in methanol and acetone at -20°C. Slides were washed twice with PBS and incubated with a mouse anti-x-tubulin monoclonal antibody (Sigma Chimie, France) for 1 h at 37°C. After a 15 min wash in PBS, the cells were stained with a fluorescein-conjugated goat antimouse antibody (diluted 1:20 in PBS/BSA/sodium azide) (Sanbio-Monosan, obtained from Tebu, Le Perray en Yvelines, France) for 45 min at 37°C and washed again in PBS. The slides were mounted with an anti-fading solution and analysed with a laser scanning confocal fluorescence microscope (MRC 600, Bio-Rad). Table I lists the general characteristics of J82 and J82-NVB cells. The doubling times at non-confluence were similar for J82 (18 ± 5 h) and J82-NVB (19 ± 4 h) cells. The cell diameters and protein contents were not significantly In order to determine the accumulation of navelbine in the sensitive and resistant J82 cells as a function of incubation time, J82 and J82-NVB cells (239 ± 42 cells mm-2) were incubated for 0.5, 1, 2 and 3 h in RPMI-1640 medium containing 2 JAM navelbine. J82-NVB cells accumulate slightly less navelbine than J82 cells (1.7-fold less after 1 h incubation with 2,M navelbine) (Figure 1 ). Drug efflux cannot account for this difference since when 1 h-treated cells were incubated in drug-free medium for 0.5, 1 and 3 h, efflux rates were similar in resistant and sensitive cells (Figure 2 ). Verapamil 5 AM decreased the efflux rate, but intracellular concentrations of navelbine remained similar in J82 and J82-NVB cells. This decrease in efflux rate could explain the increased growth-inhibitory effect of navelbine in the presence of verapamil. No additional HPLC peaks indicative of metabolites were observed in the chromatograms.
Results

General cell characteristics
Accumulation of navelbine in J82 and J82-NVB cells was also determined as a function of extracellular drug concentration. J82 and J82-NVB cells (231 ± 32 cells mm-2) were incubated for 1 h with 1, 2, 4 and 8 JIM navelbine. The intracellular concentrations of navelbine were found to be directly proportional to the extracellular concentrations (Figure 3 ). Comparing accumulation and cytotoxicity of the drug, it appears that for the same intracellular concentration, navelbine induced more growth inhibition in J82 than in J82-NVB cells. For example, a 281 pmol 106 cells intracellular concentration of navelbine corresponds to an extracel- Under these conditions, accumulation of navelbine was similar in J82 and J82-NVB cells and lower than in nonconfluent cells (Table III) . Navelbine concentration was decreased more in J82 than in J82-NVB confluent cells compared with non-confluent cells.
The effect of confluence on navelbine cytotoxicity was also tested. Confluent (2,020 ± 190 cells mm-2) and non-confluent (235 ± 39 cells mm-2) cells were incubated as described in the Materials and methods section. After a 1 h incubation with navelbine, cells were trypsinised and plated at 230 cells mm-2 (non-confluent) in drug-free medium for 72 h. Counting was performed as described above. When cells were incubated at confluence, the cytotoxicity of the drug was decreased compared with non-confluent cells. This effect was more important in J82 than in J82-NVB cells so that the resistance factor was decreased from 17 to 10 (Table III) . This confirms that a decreased uptake is not responsible for J82-NVB cell resistance since navelbine accumulation is similar in confluent J82 and J82-NVB cells but induced more growth inhibition in J82 cells.
P-glycoprotein expression
Flow cytometric analysis showed that P-glycoprotein was overexpressed in the K562-NVB cell sublines and in K562-ADM cells compared with K562 cells (Figure 4a , b, e and f). Conversely, P-glycoprotein expression was not increased in J82-NVB cells compared with J82 cells (Figure 4c and d) .
No P-glycoprotein overexpression was detected in J82 or in J82-NVB cells using immunocytochemistry with C219 antibodies (not shown). P-glycoprotein was detected in the membrane of K562-ADM cells but not in that of K562 cells, used as positive and negative controls respectively.
Total and polymerised tubulin amounts a-and P-tubulin mRNA expressions were found to be similar in J82 and J82-NVB cells by Northern blot analysis ( Figure  5 ). The amounts of polymerised tubulin determined by enzyme-linked immunoassay were similar in J82 and J82-NVB cells.
Immunofluorescence study of microtubules K562-NVB 50 (a), K562-NVB 100 (b), J82 (c), J82-NVB (d), K562 (e), and K562-ADM (f), cells were stained using an anti-Pglycoprotein antibody coupled to fluorescein. K562 and K562-ADM cells were used as negative and positive control respectively. Clear area, isotypic control; grey area, assay with the C219 antibody.
cells treated with 50 nM navelbine, no depolymerisation occurred. With 200 nM navelbine, a complete depolymerisation of the microtubular network was observed in 25% of the sensitive cells (Figure 6c ) and in 29% of the resistant cells (Figure 6d ). With 1,000 nM navelbine, microtubules appeared completely disassembled in more than 90% of the cells. With 2,000 nM navelbine, a complete depolymerisation of the microtubules was observed in both sensitive and resistant cells (Figure 6e and f) . So depolymerisation mechanism was also tested. When the cells were treated with 2,000 nM navelbine for 1 h and then incubated for an additional 6 h in drug-free medium, reassembly of microtubules was observed only in resistant and not in sensitive cells (Figure 6g and h) . The same result was obtained with vinblastine. On the contrary, no reversibility was observed after treatment of the cells with 2,000 nM colchicine (not shown).
Effect of cycloheximide on cell resistance and on reassembly of microtubules We have tested the effect of cycloheximide, an inhibitor of protein synthesis, on the resistance of J82-NVB cells. The growth inhibition assay was performed as described in the Materials and methods section. J82 and J82-NVB cells were incubated for 1 h in medium containing navelbine with or without 50 fg ml-' cycloheximide. The cells were then washed and incubated in drug-free medium for 72 h. Cell numbers were then determined. The IC50 of navelbine was not modified by the treatment with cycloheximide in sensitive cells but was slightly decreased in resistant cells (Table IV) . The resistance factor was decreased from 17 to 11. The cells were also treated for 1 h in medium containing 2,000 nM navelbine and 501agml-' cycloheximide and then incubated for 6 h in medium containing 50 S,g ml-' cycloheximide but without navelbine. Microtubules were studied as described above. Reassembly of microtubules was observed in resistant cells even in the presence of cycloheximide (data not shown). a e Figure 6 Study of the microtubular network of J82 and J82-NVB cells using immunofluorescence. J82 (a, c, e and g) and J82-NVB (b, d, f and h) cells were incubated for 1 h in RPMI medium, free of drug (a and b) or containing 200 nM (c and d) or 2,000 nM (e and f) navelbine. In order to study the reversibility of microtubule depolymerisation, the cells, incubated for 1 h with 2,000 nM navelbine, were incubated for an additional 6 h in drug-free medium (g and h). The cells were fixed and tubulin was stained using a mouse anti-a-tubulin antibody followed by a fluorescein-conjugated anti-mouse antibody. The slides were viewed with a laser scanning confocal fluorescence microscope (MRC 600, Bio-Rad). Bar = 15 gm.
Discussion
In the present study, we have described the characteristics of a bladder carcinoma cell line, J82-NVB, selected for resis- (Pelletier et al., 1990) . We have studied navelbine accumulation and cytotoxicity in confluent and non-confluent J82 and J82-NVB cell monolayers. We have shown that cell confluence could induce some resistance to navelbine in J82 cells and to a lower extent in J82-NVB cells. However, the difference of cohesion between J82 and J82-NVB cell monolayers can only account for a small part of the level of resistance to navelbine, and this resistance level could only be explained by the involvement of some other mechanism.
Apart from mechanism involving a drecreased accumulation of the drug, other types of resistance to vinca alkaloids have been described. These drugs have been reported to affect glutathione metabolism (Beck, 1980; Whelan et al., 1992), but the involvement of this mechanism in vinca alkaloid resistance has not been proved. Intracellular redistribution of the drug should also be considered since such a mechanism has been described in several resistant cell lines (Hindenburg, 1987; Cole, 1992) . However, this mechanism could induce resistance to several functionally unrelated drugs while J82-NVB cell resistance is limited to vinca alkaloids and taxoids which share a common target site: tubulin (Gueritte-Voegelein et al., 1991; Jordan et al., 1991) . Therefore, J82-NVB cell resistance is most probably linked to the alteration of some microtubule property. Several reports have described various modifications of tubulin in vinca alkaloid-resistant cell lines. A diminished amount (Tsuruo et al., 1986a; Ohta et al., 1993) or an increased amount of tubulin has been described in resistant cell lines. However, the study of a-and P-tubulin expression showed no difference between J82 and J82-NVB cell lines. Structural alterations of tubulin in resistant cells could lessen the affinity of tubulin for the drug (Pain et al., 1988) or induce the hyperstabilisation of the microtubules (Cabral & Barlow, 1989) . However, cells possessing hyperstable microtubules are cross-resistant to depolymerising drugs such as vinca alkaloids and colchicine and hypersensitive to stabilising drugs such as taxol (Keates et al., 1981; Minotti et al., 1991) . This is not the case for our J82-NVB cells, which are sensitive to colchicine and cross-resistant to taxol and taxotere. So, it seems unlikely that hyperpolymerisation of tubulin could be responsible for J82-NVB cell resistance. Moreover, the amounts of polymerised tubulin were found to be similar in J82 and J82-NVB cells.
We have shown that the resistance of J82-NVB cells is linked to the differentiation state of the cells (V. Debal et al., submitted) . When the resistant cells were differentiated by retinoic acid, their resistance was lost. This shows that the mechanism of resistance is not due to tubulin mutation, but rather to modifications of some mechanism regulating microtubule dynamics.
Using immunofluorescence, we have studied the microtubules of J82 and J82-NVB cells treated with navelbine. After incubation with navelbine, depolymerisation of the microtubules occurred at nearly the same drug concentration in sensitive and in resistant cells. This shows that even in resistant cells the drug reached its target and was not sequestered in some subcellular compartment. Microtubule depolymerisation in J82 cells treated for 1 h with navelbine occurred approximately at the drug concentration which induced a growth inhibition, while in J82-NVB cells growth inhibition occurred at concentrations higher than those inducing depolymerisation. So, the effect of the drug on microtubules was nearly the same in sensitive and in resistant cells, but resistant cells could survive after removal of the drug whereas sensitive cells could not. Thus, recovery from the inhibition of microtubule dynamics induced by navelbine is probably responsible for the resistance of J82-NVB cells.
In order to study this recovery mechanism, we have tested the reversibility of microtuble depolymerisation in sensitive and resistant cells. After treatment with 2,000 nM navelbine, reassembly of the microtubular network was observed in resistant but not in sensitive cells. The same result was obtained with vinblastine. Moreover, no reversibility was observed after treatment with colchicine, to which the cells are not resistant. This confirms that the mechanism of resistance of J82-NVB cells is at the level of microtubules and involves recovery of microtubule dynamics.
Some mechanisms allowing recovery from cellular damage induced by protein alteration have already been described. They generally involve the synthesis of proteins of the family of molecular chaperones (Ellis & Van der Vries, 1991) . Moreover, molecular chaperone proteins play an essential role in the in vivo assembly of microtubules (Gupta, 1990) . Some of these proteins have been reported to induce cell resistance to vinca alkaloids (Huot et al., 1991; Lee et al., 1992) , and these newly synthesised proteins have been found to bind to tubulin in these resistant cells (Lee et al., 1992) . We have tested the effect of cycloheximide, an inhibitor of protein synthesis, on the resistance of J82-NVB cells to navelbine. The presence of cycloheximide during the incubation of J82-NVB cells with navelbine results in only a slight decrease of resistance, and reassembly of microtubules occurs in J82-NVB cells even in the presence of cycloheximide. Thus it seems that protein synthesis is not essential for the recovery to occur.
The cross-resistance observed between vinca alkaloids and taxoids may appear rather surprising since vinca alkaloids, like colchicine, are microtubule-depolymerising drugs, contrary to taxol, which promotes tubulin polymerisation (Schiff et al., 1979) . However, it has been shown that the antiproliferative action of vinca alkaloids at low concentration results from stabilisation of microtubule dynamic instability rather than from depolymerisation of microtubules (Jordan et al., 1991; Toso et al., 1993) . Recently, it has been shown that taxol, at low concentration, shares a common antiproliferative mechanism with vinca alkaloids . In our cells, low concentrations of the drug remained after removal of the drug from the medium. Under these conditions, the mechanism of action of vinca alkaloids and taxol analogues are similar. Moreover, cross-resistance between vinca alkaloids and taxol has already been observed in another non-MDR cell line resistant to microtubule poisons (Ohta et al., 1993) . Other authors have studied the reversibility of microtubules bundling induced by taxol in different leukaemia cell lines (Rowinsky et al., 1988) . They concluded that in cells that were relatively resistant to taxol microtubule bundling was reversible, unlike in relatively sensitive cells, in which microtubule bundles persisted.
All these results are consistent with our study, which suggests that the mechanism of resistance of J82-NVB cells is mainly recovery from the inhibition of microtubule dynamism induced by the drug.
